Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer

@article{Fujitani2011PosttherapyNS,
  title={Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer},
  author={Kazumasa Fujitani and Masayuki Mano and Motohiro Hirao and Yoshinori Kodama and Toshimasa Tsujinaka},
  journal={Annals of Surgical Oncology},
  year={2011},
  volume={19},
  pages={1936-1943}
}
Neoadjuvant chemotherapy (NAC) has been attempted as a means of improving survival of potentially resectable advanced gastric cancer (AGC). In the course of exploring the most promising NAC regimen, a superior surrogate marker reflecting overall survival (OS) is necessary. We investigated prognostic factors in AGC patients who underwent NAC followed by gastric resection and evaluated whether histologic response to NAC was predictive of survival. Seventy consecutive patients with gastric cancer… CONTINUE READING
8 Citations
29 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Multicenter phase II study of triple combination with S-1 and cisplatin (CDDP) plus paclitaxel (TXL) in patients with advanced gastric cancer

  • H Iwase, T Tsuzuki, M Shimada
  • J Clin Oncol
  • 2008

Similar Papers

Loading similar papers…